AQST · Aquestive Therapeutics Inc
United States · RS rating 73 · As of 2026-10-14
| Price | 4.61 USD |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 73 / 40 / 90 / 21 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 24 / 30 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -85.7% |
| Sales growth Q/Q | +1.6% |
| Distance from 52-week high | +38.5% |
| Market cap (USD) | $496.7M |